Bayer and Aignostics to collaborate on next generation precision oncology Not intended for UK Media Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s...

Aignostics Raises €14m Series A to Advance AI-powered Pathology Oversubscribed financing round with top-tier life science investors, led by Wellington PartnersSpin-off from Charité – Universitätsmedizin Berlin developing sophisticated AI models to improve...